MRNA: Acute trade projection:
-FDA approval of booster doses
-Positive news released regarding extended antibody/variant response
-Optimal buy zone at base of sigma channel, could revisit 457 level price shelf from here
-Key levels:
Resistance: 419.38, 428.77
Support: 390.41, 377.10
-FDA approval of booster doses
-Positive news released regarding extended antibody/variant response
-Optimal buy zone at base of sigma channel, could revisit 457 level price shelf from here
-Key levels:
Resistance: 419.38, 428.77
Support: 390.41, 377.10
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.